{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:41:20Z","timestamp":1793400080896,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["5252022"],"award-info":[{"award-number":["5252022"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32371490"],"award-info":[{"award-number":["32371490"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymthe.2026.01.027","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:26:58Z","timestamp":1769128018000},"page":"3373-3387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Myeloid-lineage CAR knockin mice enable allogeneic immunotherapy for liver and lung fibrosis"],"prefix":"10.1016","volume":"34","author":[{"given":"Min","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiao","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7599-1062","authenticated-orcid":false,"given":"Shuyue","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiushan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7688-5955","authenticated-orcid":false,"given":"Luo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.01.027_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41584-019-0324-5","article-title":"Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases","volume":"16","author":"Hinz","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ymthe.2026.01.027_bib2","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis--a common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.01.027_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.027_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.01.027_bib5","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.molmed.2023.08.010","article-title":"Pulmonary fibrosis: from pathogenesis to clinical decision-making","volume":"29","author":"Koudstaal","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2026.01.027_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","article-title":"Targeting fibrosis, mechanisms and clinical trials","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.01.027_bib7","first-page":"32","article-title":"Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer","volume":"7","author":"Tokhanbigli","year":"2024","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.ymthe.2026.01.027_bib8","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1007\/s00259-022-05706-y","article-title":"Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond","volume":"49","author":"Li","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ymthe.2026.01.027_bib9","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1038\/s41467-022-34870-w","article-title":"PEAR1 regulates expansion of activated fibroblasts and deposition of extracellular matrix in pulmonary fibrosis","volume":"13","author":"Geng","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.01.027_bib10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.01.027_bib11","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s11010-024-05134-6","article-title":"Targeting cardiac fibrosis with Chimeric Antigen Receptor-Engineered Cells","volume":"480","author":"Zhang","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ymthe.2026.01.027_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-019-0051-2","article-title":"'Off-the-shelf' allogeneic CAR T cells: development and challenges","volume":"19","author":"Depil","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.01.027_bib13","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/s41467-025-59093-7","article-title":"Targeted immunotherapy rescues pulmonary fibrosis by reducing activated fibroblasts and regulating alveolar cell profile","volume":"16","author":"Yan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.01.027_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.01.027_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114760","article-title":"Fibroblast activation protein-targeted chimeric antigen-receptor-modified NK cells alleviate cardiac fibrosis","volume":"157","author":"Zheng","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ymthe.2026.01.027_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fimmu.2018.00127","article-title":"Macrophage Clearance of Apoptotic Cells: A Critical Assessment","volume":"9","author":"Gordon","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.027_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10555","article-title":"Macrophage-based delivery of anti-fibrotic proteins alleviates bleomycin-induced pulmonary fibrosis in mice","volume":"8","author":"Liu","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.01.027_bib18","doi-asserted-by":"crossref","first-page":"9575","DOI":"10.1038\/s41467-024-53700-9","article-title":"Induction of a distinct macrophage population and protection from lung injury and fibrosis by Notch2 blockade","volume":"15","author":"Cruz Tleugabulova","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.01.027_bib19","article-title":"Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease","volume":"5","author":"Martinez-Sanchez","year":"2023","journal-title":"JHEP Rep."},{"key":"10.1016\/j.ymthe.2026.01.027_bib20","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jhep.2024.01.034","article-title":"Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models","volume":"80","author":"Dai","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymthe.2026.01.027_bib21","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/CIRCRESAHA.124.325212","article-title":"CAR-Macrophage Therapy Alleviates Myocardial Ischemia-Reperfusion Injury","volume":"135","author":"Wang","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2026.01.027_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.immuni.2020.06.014","article-title":"Immune Sensing Mechanisms that Discriminate Self from Altered Self and Foreign Nucleic Acids","volume":"53","author":"Bartok","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.01.027_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.783305","article-title":"Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors","volume":"12","author":"Sloas","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.027_bib24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41416-023-02319-6","article-title":"Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer","volume":"129","author":"Dong","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2026.01.027_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.omtm.2021.03.015","article-title":"Efficient lentiviral transduction method to gene modify cord blood CD8(+) T cells for cancer therapy applications","volume":"21","author":"Lo Presti","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.01.027_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12860-021-00397-z","article-title":"Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells","volume":"22","author":"Rajabzadeh","year":"2021","journal-title":"BMC Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.01.027_bib27","first-page":"1471","article-title":"Optimized protocols for gammadelta T cell expansion and lentiviral transduction","volume":"19","author":"Wang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ymthe.2026.01.027_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21886","article-title":"Enhanced infection efficiency and cytotoxicity mediated by vpx-containing lentivirus in chimeric antigen receptor macrophage (CAR-M)","volume":"9","author":"Gao","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ymthe.2026.01.027_bib29","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.01.027_bib30","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41581-022-00624-6","article-title":"Progress in xenotransplantation: overcoming immune barriers","volume":"18","author":"Sykes","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ymthe.2026.01.027_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12744","article-title":"Progressive genetic modifications of porcine cardiac xenografts extend survival to 9 months","volume":"29","author":"Mohiuddin","year":"2022","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.ymthe.2026.01.027_bib32","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1053\/j.semnuclmed.2022.04.002","article-title":"Advancement and Future Perspective of FAPI PET\/CT In Gynecological Malignancies","volume":"52","author":"Dendl","year":"2022","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.ymthe.2026.01.027_bib33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","article-title":"Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ymthe.2026.01.027_bib34","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3390\/cancers14051231","article-title":"Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets","volume":"14","author":"Czekay","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2026.01.027_bib35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature13807","article-title":"Pulmonary macrophage transplantation therapy","volume":"514","author":"Suzuki","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.01.027_bib36","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cell.2014.11.018","article-title":"Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment","volume":"159","author":"Lavin","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.01.027_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.01.027_bib38","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1158\/1078-0432.CCR-20-3863","article-title":"CRISPR\/Cas9-Engineered Universal CD19\/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed\/Refractory B-cell Acute Lymphoblastic Leukemia","volume":"27","author":"Hu","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.01.027_bib39","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.2022016204","article-title":"Genome-edited allogeneic donor \u201cuniversal\u201d chimeric antigen receptor T cells","volume":"141","author":"Qasim","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.01.027_bib40","article-title":"Abrogation of HLA surface expression using CRISPR\/Cas9 genome editing: a step toward universal T cell therapy","volume":"10","author":"Lee","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.01.027_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009750","article-title":"Pulmonary transplantation of macrophage progenitors as effective and long-lasting therapy for hereditary pulmonary alveolar proteinosis","volume":"6","author":"Happle","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.01.027_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/d41591-025-00020-0","article-title":"World-first pig kidney trials mark turning point for xenotransplantation","author":"Healey","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.01.027_bib43","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41590-023-01454-9","article-title":"Novel mouse models based on intersectional genetics to identify and characterize plasmacytoid dendritic cells","volume":"24","author":"Valente","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.027_bib44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12943-024-02184-8","article-title":"Chimeric antigen receptor macrophages targeting c-MET(CAR-M-c-MET) inhibit pancreatic cancer progression and improve cytotoxic chemotherapeutic efficacy","volume":"23","author":"Zheng","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2026.01.027_bib45","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s42003-024-07009-4","article-title":"DNA origami assembled spheroid for evaluating cytotoxicity and infiltration of chimeric antigen receptor macrophage (CAR-M)","volume":"7","author":"Zhu","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ymthe.2026.01.027_bib46","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.7150\/thno.100116","article-title":"Collagen type I PET\/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies","volume":"14","author":"Esfahani","year":"2024","journal-title":"Theranostics"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:18:50Z","timestamp":1788178730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626000286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1525001626000286"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.01.027","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid-lineage CAR knockin mice enable allogeneic immunotherapy for liver and lung fibrosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}